Pulmonary Neuroendocrine Cells and Small Cell Lung Carcinoma: Immunohistochemical Study Focusing on Mechanisms of Neuroendocrine Differentiation-Reference-Cited by-同舟云学术

Pulmonary Neuroendocrine Cells and Small Cell Lung Carcinoma: Immunohistochemical Study Focusing on Mechanisms of Neuroendocrine Differentiation

Published:2022-06-29 Issue:3 Volume:55 Page:75-83
ISSN:0044-5991
Container-title:ACTA HISTOCHEMICA ET CYTOCHEMICA
language:en
Short-container-title:Acta Histochem. Cytochem

Author:

Ito Takaaki¹,Kudoh Shinji¹,Fujino Kosuke¹,Sanada Mune²,Tenjin Yuki¹,Saito Haruki¹,Nakaishi-Fukuchi Yuko³,Kameyama Hiroki³,Ichimura Takaya⁴,Udaka Naoko⁵,Kudo Noritaka¹,Matsuo Akira¹,Sato Younosuke¹

Affiliation:

1. Department of Pathology and Experimental Medicine, Kumamoto University Graduate School of Medical Sciences

2. Department of Respiratory Surgery, Kumamoto University Graduate School of Medical Sciences

3. Department of Medical Technology, Faculty of Health Science Kumamoto Health Science University

4. Department of Pathology, Saitama Medical School

5. Division of Surgical Pathology, Yokohama City University Hospital

Publisher

Japan Society of Histochemistry & Cytochemistry

Subject

Cell Biology,Histology,Physiology,Biochemistry,Pathology and Forensic Medicine

Link

https://www.jstage.jst.go.jp/article/ahc/55/3/55_22-00031/_pdf

Reference60 articles.

1. 1 Abe, H., Naito, Y., Sadashima, E., Fukushima, C., Takase, Y., Murata, K., et al. (2019) Insulinoma-Associated Protein 1 (INSM1) is a novel diagnostic marker of small cell lung cancer in bronchial brushing and pleural effusion cytology cell blocks: Reliability and cut-off value of INSM1. Cancer Cytopathol. 127; 598–605.

2. 2 Alexandrov, L., Ju, Y., Haase, K., Van Loo, P., Martincorena, I., Nik-Zainal, S., et al. (2016) Mutational signatures associated with tobacco smoking in human cancer. Science 354; 618–622.

3. 3 Augustyn, A., Borromeo, M., Wang, T., Fujimoto, J., Shao, C., Dospoy, P. D., et al. (2014) ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers. Proc. Natl. Acad. Sci. U S A 111; 14788–14793.

4. 4 Baine, M. K., Hsieh, M. S., Lai, W. V., Egger, J. V., Jungbluth, A. A., Daneshbod, Y., et al. (2022) SCLC subtypes defined by ASCL1, NEUROD1, POU2F3, and YAP1: A comprehensive immunohistochemical and histopathological characterization. J. Thorac. Oncol. 15; 1823–1835.

5. 5 Ball, D. W. (2004) Achaete-scute homolog-1 and Notch in lung neuroendocrine development and cancer. Cancer Lett. 204; 159–169.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bromodomain Protein-directed Agents and MYC in Small Cell Lung Cancer;Current Cancer Drug Targets;2024-09

2. Evaluation and clinical significance of serum neurospecific enolase in children with pneumonia: a case-control study;BMC Pediatrics;2024-05-31

3. The Evolving Scenario of ES-SCLC Management: From Biology to New Cancer Therapeutics;Genes;2024-05-27

4. Molecular pathology of small cell lung cancer: Overview from studies on neuroendocrine differentiation regulated by ASCL1 and Notch signaling;Pathology International;2024-04-12

5. Small cells – big issues: biological implications and preclinical advancements in small cell lung cancer;Molecular Cancer;2024-02-24